Globally, these findings support a growing evidence suggesting that the activation of the NLRP3 inflammasome actively contributes to the inflammatory response that drives cardiovascular diseases, particularly when associated to metabolic alterations43,44. The gene discussed is NLRP3; the disease is cardiovascular disorder.